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The advantage of stepped vitrification (SV) is avoiding ice crystal nucleation, while decreasing the 
toxic effects of high cryoprotectant concentrations. We aimed to test this method for human ovarian 
tissue cryopreservation. Ovarian cortex was taken from 7 fertile adult women. Samples were subjected 
to an SV protocol performed in an automatic freezer, which allowed sample transfer to ever higher 
concentrations of dimethyl sulfoxide (DMSO) as the temperature was reduced. Histological evaluation 
of the vitrified-warmed tissue showed large numbers of degenerated follicles after 24 hours of in vitro 
culture. We therefore evaluated DMSO perfusion rates by X-ray computed tomography, ice crystal 
formation by freeze-substitution, and cell toxicity by transmission electron microscopy, seeking 
possible reasons why follicles degenerated. Although cryoprotectant perfusion was considered normal 
and no ice crystals were formed in the tissue, ultrastructural analysis detected typical signs of DMSO 
toxicity, such as mitochondria degeneration, alterations in chromatin condensation, cell vacuolization 
and extracellular matrix swelling in both stromal and follicular cells. The findings indicated that the 
method failed to preserve follicles due to the high concentrations of DMSO used. However, adaptations 
can be made to avoid toxicity to follicles caused by elevated levels of cryoprotectants.
These days, human fertility preservation should be considered a complement of cancer treatments1. Indeed, 
thanks to substantial improvements in treatment and prognosis, ovarian tissue cryopreservation is a technique 
that has been gaining ground2, not only to safeguard fertility, but also to restore hormone levels in women sub-
jected to gonadotoxic treatments or in the menopause3. Results obtained so far are promising, with more than 
130 babies born to date, and the technique is now on the verge of becoming a possible routine approach and no 
longer experimental4.
Ovarian tissue obtained from these patients is a very precious source of germ cells for fertility preservation, so 
assays to improve its manipulation have been constantly under development. Slow-freezing (SF) is the most com-
mon method used for human ovarian tissue cryopreservation today5, derived from a protocol described several 
decades ago for sheep ovarian tissue6.
The main challenge faced during freezing is formation of ice within the tissue, as reducing the temperature 
leads to ice crystal formation due to ice nucleation. This phenomenon is followed by crystal growth when the 
molecular arrangement of water is altered to a solid pattern7. When the temperature falls very fast, there is no 
time or energy for molecular rearrangement, so there is no ice crystal formation; the natural disorder of liquid 
molecules in tissue is maintained, mitigating any disturbance to the system. This forms the basis of the vitrifi-
cation concept, as the absence of crystals prevents cell membrane damage normally caused by their mechanical 
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activity. While vitrification protocols are already well established for oocytes8 and embryos9, tissue vitrification 
remains a challenge because of its variety in composition and size.
Vitrification procedures have been optimized by increasing the viscosity of the solution, which lowers the 
melting temperature (MT) of the sample and results in its dehydration. In normal conditions, if temperatures 
drop before the MT is reached, ice formation occurs. However, if the liquid viscosity is increased, crystal for-
mation is avoided7,10. On the other hand, an increase in viscosity requires high concentrations of cryoprotective 
agents (CPAs) in order to extract water from the tissue, which may create other problems, namely toxic effects 
suffered by cells11.
To avoid this issue, samples can be subjected to a low temperature environment, with low rates of potential 
energy and cell metabolism. Consequently, molecules become less mobile and more stagnant, but remain disor-
dered. Based on work first described by Farrant in 196512, a procedure known as liquidus tracking was developed 
by Pegg et al. to cryopreserve cartilage13, involving enhancement of CPA concentrations in samples while decreas-
ing their temperature14. This equilibrium procedure prevents ice crystal formation (thanks to high concentra-
tions of CPAs) and decreases cell susceptibility to toxic effects (thanks to low temperatures). The same technique 
has been tested in bovine ovarian tissue15, yielding good rates of CPA perfusion and morphology maintenance. 
Nevertheless, species-specific responses may vary, especially in human tissue. The aim of this work was therefore 
to evaluate the effectiveness of a stepped vitrification (SV) protocol based on the liquidus tracking technique in 
terms of maintenance of the structural characteristics and morphology of human ovarian follicles.
Results
Histological analysis. Analysis of fresh controls before and after in vitro culture (IVC) yielded high percent-
ages of morphologically normal follicles: 98.9 ± 17.7% and 94.5 ± 5.4% respectively. Some of these normal folli-
cles found in our samples are shown in Fig. 1. On the other hand, vitrified-warmed ovarian cortex exhibited signs 
of degeneration in both follicles and stroma after IVC, as shown in Fig. 2. Unfortunately, 100% of follicles were 
degenerated. They contained oocytes with strong eosinophilic cytoplasmic staining and shrinkage, and either a 
pyknotic or absent nucleus, confirming their degenerated status. Granulosa cells also showed signs of pyknosis 
and were arranged in a disorganized way. In tissue, a large proportion of stromal cells showed pyknotic nuclei 
and fibrotic deposits.
X-ray computed tomography. Analysis at −140 °C revealed no difference in attenuation between tissue 
and surrounding medium in two out of three samples evaluated by Nano computed tomography (CT), indi-
cating that the system was well equilibrated (Fig. 3A–C). In one of the samples, although tissue could barely be 
distinguished from the solution in the inner part of the vial, the outer region showed higher attenuation close 
Figure 1. Fresh follicles. Morphologically normal human ovarian follicles observed in fresh ovarian tissue 
before (A,B) and after (C,D) 24 h of IVC. Bars: 50 µm.
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to its border (Fig. 4). This constitutes a normal beam hardening effect, which was corrected with CT calibration. 
Estimated DMSO concentrations in tissues are shown in Table 1.
After the warming curve was achieved and CPA removal concluded, there was no visible difference between 
X-ray attenuations of tissue samples and surrounding medium containing 0% DMSO at RT (Fig. 3D–F). This 
attenuation similarity led us to conclude that CPA removal was adequate after warming.
Freeze-substitution. Human ovarian tissue fixed at low temperatures after equilibrium vitrification showed 
no signs of ice crystal formation, confirmed by normal attachment between cells and no empty spaces in the 
tissue (Fig. 5A). In sheep ovarian tissue cryopreserved using an inefficient technique (Fig. 5B) and serving as a 
control for comparative purposes, we detected large empty spaces corresponding to ice crystals formed during 
the freezing procedure.
Transmission electron microscopy. Follicles (n = 3) from fresh and vitrified-warmed tissue from three 
patients were localized and analyzed by TEM. They were all at primordial or primary stages of development.
Fresh tissue contained stromal cells of varying shape, usually with moderately dispersed chromatin. Among 
these stromal cells, deposits of collagen fiber beams differed from patient to patient, being thicker and more 
scattered in one subject. Nevertheless, stromal cells from all patients showed signs of morphology maintenance 
(Fig. 6A). Follicles had a well preserved oocyte (Fig. 6C) with numerous mitochondria of normal shape (round 
or cylindrical) and electron density, usually located close to the nuclear envelope (Fig. 6C,E) and frequently 
surrounding a small, dense, amorphous granule (Fig. 6E’). Some lysosomes and small lipid droplets were also 
present. The cytoplasm exhibited a uniform granular background (Fig. 6E,G), while nuclei showed dispersed 
heterochromatin and a well preserved nuclear envelope (Fig. 6E). Adequate attachment was maintained between 
granulosa cells and oocytes, as well as microvilli (Fig. 6G). A continuous and intact basal membrane layer between 
the granulosa and stromal cells evidenced the expected appropriate follicle morphology (Fig. 6G,H).
Since no preserved follicles were found by light microscopy after IVC, we decided to analyze ovarian tissue 
ultrastructure immediately after warming in order to identify any alterations typically caused by cryopreser-
vation. Although cell metabolism and activity were not entirely reestablished, clear signs of degeneration were 
already visible in cell ultrastructure. It is important to state that during analysis of semi-thin sections by toluidine 
blue staining under light microscopy, it was difficult to detect signs of degeneration (200x magnification).
Stromal cells showed condensed chromatin, poorly preserved organelles and numerous vacuoles in their cyto-
plasm (Fig. 6B). Oocyte organelles were not preserved (Fig. 6D) and displayed enlarged rough endoplasmic retic-
ulum cisternae, either with flocculent content or in the form of a clear vacuolar structure, sometimes surrounded 
Figure 2. Vitrified-warmed follicles. Human ovarian follicles observed after vitrification-warming and 24 h of 
IVC. We can identify degenerated follicles with a shrunken oocyte cytoplasm and pyknotic and disorganized 
granulosa cells (A–C), as well as fibrotic tissue among stromal cells. (D) Bars: 50 µm in A and B; 20 µm in C; 
200 µm in D.
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by detached clustered ribosomes (Fig. 6F). Mitochondria exhibited clear signs of degeneration, such as disrupted 
shape, slightly clarified matrices and the remains of cristae (Fig. 6F). Large vacuoles were also observed through-
out the cytoplasm, as was degeneration of cell membranes in terms of detachment and disintegration of the lipid 
bilayer (Fig. 6H). The nucleus consistently showed a dense and disorganized chromatin structure, with degener-
ation of the nuclear envelope and clear signs of pyknosis (Fig. 6D).
Discussion
In this study we evaluated a new vitrification procedure for cryopreservation of human ovarian tissue. However, 
results from histological analysis were initially discouraging, since no normal follicles were found. We therefore 
investigated, examining possible reasons why follicle structure was not maintained. Since the main obstacles 
encountered during cell cryopreservation are ice crystal formation and CPA toxicity, subsequent evaluations were 
directed at these two possibilities.
CT analysis found DMSO concentrations to be adequate, and the morphological appearance of ovarian tissue 
after freeze-substitution confirmed no ice crystal formation. A number of alterations to the ultrastructure of folli-
cles were identified by TEM, however revealing that CPA toxicity was responsible for the lack of normal follicles.
Although SF is the most commonly adopted protocol for human ovarian cryostorage today, there is great 
interest in vitrification systems. Superior results have indeed been obtained with vitrification compared to SF in 
terms of follicle viability16, DNA fragmentation, proportion of intact preantral follicles17, preservation of stromal 
cells18, and follicle density and activation rates19. A recent review and meta-analysis20 concluded that vitrification 
may well be more effective than SF, but the authors stressed that variations in protocols could negatively impact 
the dissemination of the technique and its application in routine clinical practice. It is, therefore reasonable to 
wonder why a preference to SF still persists. One possible answer is that in addition to the threat of CPA toxicity, 
direct tissue contact with non-sterile liquid nitrogen could deter practitioners from attempting vitrification21. 
Figure 3. DMSO perfusion assessed by computed tomography. CT images obtained at −140 °C and at RT 
from three different patients (P2, P6 and P7) showing vitrified and warmed ovarian cortex. Spatial resolution 
is 0.2 mm and the color scale runs from dark blue for low attenuation (1.2 CT, lower concentrations of DMSO) 
to intense red for high attenuation (3.0 CT, higher concentrations of DMSO). Blue-colored squares shown in 
all images are volumes of interest (VOIs) located within the tissue to obtain statistical data on attenuation and 
DMSO concentrations. Tissue can barely be distinguished from surrounding medium in A and C, while in B it 
can be partly differentiated, showing less attenuated coloration (yellow) than medium containing 50% DMSO 
(red). After cryoprotectant removal, there is no difference in attenuation levels in the vials at RT. RT: room 
temperature.
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However, this second issue may be avoided by using the Cryotop method22, pooled straws23 or even cryotubes, as 
described in the present work, so CPA toxicity remains the main concern.
The effects of this toxicity led us to consider the alternative of SV in humans, which was recently successfully 
tested for the first time in ovarian tissue15. While results obtained in bovine tissue were promising in terms of fol-
licle morphology preservation, this was not the case in the present study. One of the reasons for the discrepancy 
may have been that Corral et al. did not proceed to IVC after warming, aware that omission of this step could 
impair recognition of organelle changes due to toxicity. It is noteworthy that tissue fixed right after warming in 
the present study did not show obvious signs of degeneration either when analyzed by light microscopy (200x 
magnification with toluidine blue staining), but it was detected upon ultrastructural analysis. This confirms the 
need for an incubation step of at least 24 hours of IVC to evidence the impact of the SV method on follicle viabil-
ity by histology, as previously reported24. The opposite findings could also be explained by the heterogeneity in 
plasmatic membrane composition between different species and types of cells25, since in articular cartilage13 and 
encapsulated liver cells26, for example, the SV protocol proved extremely efficient at maintaining cell viability and 
functionality.
During cryopreservation, ice nucleation occurs when the MT is reached, followed by its growth in water 
molecules, which rearrange themselves in an orderly manner aiming to form a solid crystal7. This rearrangement 
happens wherever water molecules are located, easily destroying tissue components. However, for vitrification 
to proceed properly in a stepped way, solutes in the systems need to be concentrated/viscous enough to inhibit 
nucleation27. It is known that at −40 °C, the viscosity of highly concentrated DMSO solution is increased, while 
the permeability and fluidity of membranes are decreased28, which may impair CPA perfusion. Nevertheless, our 
Figure 4. Segmented computed tomography image. Computed tomography image obtained from one sample 
at −140 °C. (A) Segmentation of the CT image showing only part of the picture with a threshold value from 
2.6 to 2.8 CT (on a scale of 0.0 to 1.0), which corresponds to a concentration of 38.2% to 44.4% v/v DMSO. The 
tissue can be distinguished at the bottom of the cryovial with a similar concentration to the medium. (B) Image 
obtained under the same conditions as in A, but with a threshold value from 2.8 to 3.0 CT, which corresponds to 
a concentration of 44.4% to 50.6% v/v DMSO. Note the effect at the borders, suggesting higher concentrations 
than the solution in the middle. (C) 3D images obtained with the same threshold value as in A. CT: cycle 
threshold.
Temperature – Patient Average CT values Average % v/v DMSO Min-Max % v/v DMSO
−140 °C
P7 2.82 (0.10) 45.2 (+0.9) 38.0–55.0
P2 2.72 (0.14) 42.0 (+0.8) 33.2–53.2
P6 2.59 (0.18) 38.1 (+0.7) 21.4–53.1
RT
P7 1.49 (0.05) 0.5 (+1.0) −4.8–7.3
P2 1.46 (0.05) −0.8 (+1.0) −6.2–4.7
P6 1.49 (0.07) 0.5 (+1.0) −6.4–8.4
Table 1. Average, minimum and maximum DMSO concentrations (% v/v) in tissues analyzed at −140 °C 
and RT, calculated from a VOI of 3 × 3 × 1 mm in the tissue, with calibration curves established for each 
temperature. The average CT error is the standard deviation of the 3 × 3 × 1 mm3 VOI, while average DMSO 
concentration errors correspond to the standard error of the mean. RT: room temperature; CT: computed 
tomography; DMSO: dimethyl sulfoxide.
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CT results showed average equilibrium percentages of DMSO to be between 38% and 45%. According to Wowk 
(2010), such DMSO concentrations in tissue ensure an absence of ice, preventing crystal nucleation at −40 °C and 
promoting formation of a vitreous state at −150 °C, the temperature of liquid nitrogen vapors7. This assumption 
was corroborated by the freeze-substitution method; since no empty spaces were detected in the ovarian tissue, 
we had confirmation of adequate CPA equilibrium that promoted appropriate externalization of water and vis-
cosity of the system.
Another important finding was the absence of DMSO in samples after warming. Remains of CPA in tissue 
have raised concerns because of their potential for damage, such as impacts on epigenetic profiles, as observed in 
embryoid bodies29. After evaluation of residual DMSO in warmed and thawed ovarian tissue, DMSO remnants 
were only found in vitrified samples30, which authors attribute to the fast warming protocol. Since warming was 
performed slowly in the present study, we achieved total of CPA removal, anticipating no long-term toxic effects 
on either the potential host or potential embryo.
Once high concentrations of DMSO had been reached and both dehydration and viscosity of compounds 
deemed adequate, and despite the temperature reduction scheme in the SV method being intended to prevent 
CPA toxicity, follicle death still ensued. This led us to attribute cell death to chilling injury or high DMSO levels. 
According to Mazur et al. (1992), chilling injury is thought to increase with exposure time to very low tempera-
tures31 and its effects are based on membrane phase transition modifications causing membrane disintegration. 
Reduced CPA toxicity under low temperature condition is related to enzyme activity decreases and lower reaction 
kinetics in general, be they chemical or osmotic stresses26. Since the toxic effects seen in the present study were 
related to membrane degeneration, they were probably caused by chemical changes in the phospholipid chain 
conformation that is not attenuated by low temperatures.
Thanks to its capacity to easily cross cell membranes, DMSO is often used in living systems for enhanced 
penetration of drugs and cryoprotection. It acts by means of three different mechanisms depending on its concen-
tration: (i) by decreasing membrane thickness when used in the range of 2.5–7.5 mol%; (ii) by inducing formation 
of transient water pores in the range of 10–20 mol%; or (iii) by permanently disorganizing the bilayer structure at 
concentrations above 25 mol%32. The cryoprotective properties of DMSO rely on membrane pore formation for 
externalization of water, but the membrane is unable to recover in concentrations over 25%, even at low temper-
atures33, as seen in the present study.
Because the toxic effects of DMSO are mostly associated with cell membrane damage34, we assessed toxicity by 
ultrastructural analysis, which is a widely applied technique35–37 that allows cell membrane evaluation. It revealed 
extensive damage to organelles and plasmatic membranes. After DMSO penetrates cells, it is distributed through-
out the cytoplasm via a microcirculatory tubule system in a directed manner38, enabling its spread through cell 
contents and dissemination to organelles. Mitochondrial alterations were indeed evident. According to Eyden 
et al. (2004), mitochondria and rough endoplasmic reticulum are the most sensitive organelles in oocytes sub-
jected to cryopreservation39. Cell vacuolization was consistently observed during our analysis and is widely 
reported in the literature; it may be related to swelling and coalescence of smooth endoplasmic reticulum and the 
Golgi apparatus or plasmatic membrane invaginations due to endocytic vesicles40–42. Irregularly shaped oocyte 
nuclei and chromatin thickening were also encountered after ovarian tissue cryopreservation36. These TEM 
Figure 5. Ice crystal formation assessment. Ovarian tissue fixed by freeze-substitution. Note the absence of 
spaces between cells and fibers in human ovarian cortex subjected to the stepped vitrification procedure (A), 
compared to control ovarian tissue subjected to an inefficient cryopreservation procedure. (B) Toluidine blue 
staining; 200x magnification; bars: 100 µm.
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findings corroborate observations of DMSO toxicity described in the literature: cell membrane disintegration 
and apoptosis induction34.
In conclusion, our results suggest that rather than preserving human ovarian tissue, 50% DMSO at −40 oC 
causes degeneration of preantral follicles and stromal cells, the concentration being too high. One way of solving 
Figure 6. Transmission electron microscopy. TEM pictures from fresh and vitrified-warmed ovarian tissue. 
(A) Good preservation of stromal cells (3000x); (C) Good morphological preservation of cells and attachment 
between the oocyte and granulosa cells, and the follicle and stroma, in a primordial follicle (700x). (E) Well 
preserved nuclear envelope (arrow) and accumulation of normal mitochondria (white asterisks) around it 
(7000x). (E’) Group of mitochondria attached to a dense amorphous granule (arrowheads). G, (G’) Preservation 
of oocyte and granulosa cell membranes, with the presence of microvilli and the basal membrane (black 
asterisks) (4000x). (B) Stromal cells showing the presence of several vacuoles in their cytoplasm (asterisks) and 
a nucleus with highly condensed chromatin (3000x). (D) Poorly preserved follicle and an oocyte nucleus with a 
pyknotic aspect and highly condensed chromatin (400x). (F) Presence of degenerated mitochondria (asterisk) 
and rough endoplasmic reticulum (rER) close to an apparent group of ribosomes (R) (4000x). (H) Presence 
of vacuoles (v) and signs of cell membrane degeneration in the oocyte (arrow) (4000x). SC: stromal cells; GC: 
granulosa cells; Nu: nucleus.
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this problem could be lowering DMSO levels in the final vitrification solution or even associating CPAs, all at 
lower concentrations. Indeed, since our objective is to increase viscosity and promote externalization of water 
from cells, this approach could mitigate membrane disintegration induced by 50% DMSO33.
Methods
Ethics and experimental design. Ovarian tissue was taken from 7 women (27–33 years of age) under-
going laparoscopic procedures for benign gynecological disease (six patients with endometriosis and/or endo-
metriomas and one with low-grade endometrial stromal sarcoma) after obtaining informed consent. Use of 
human ovarian tissue was approved by the Institutional Review Board of the Université Catholique de Louvain 
on November 28, 2016 (IRB reference 2012/23MAR/125, registration number B403201213872). All methods 
were performed in accordance with the relevant guidelines and regulations.
After removal, ovarian biopsies were immediately transported to the laboratory in Dulbecco’s Modified Eagle 
Medium (DMEM/F12; Gibco, USA) in sterile and low temperature conditions (0 °C). Once in the laboratory, the 
tissue was washed and cleaned of its medullary part, before being cut into 5 × 5 × 1 mm pieces and subjected to 
the previously described vitrification procedure15. Our experiments did not investigate conventional freezing of 
ovarian tissue, as this has been widely documented in the literature (Table 2).
Small fragments (1 × 1 × 1 mm) were used as fresh controls and immediately fixed for analysis by light and 
transmission electron microscopy (TEM). Short-term (24 hours) IVC of fresh ovarian tissue (1 × 1 × 1 mm3) was 
also performed for control purposes to ensure culture protocol effectiveness for cell morphology maintenance 
and activity. All mentioned protocols are described below.
All chemicals used were purchased from Sigma-Aldrich, unless otherwise stated.
Vitrification procedure. A programmable controlled-rate freezer was used (Asymptote, General Electric 
Healthcare, VIA Freeze Research, Sovereign House, Cambridge, UK). It was equipped with an SV device designed 
to move samples to vials with different concentrations of dimethyl sulfoxide (DMSO).
Four 3 ml vials were filled with minimal essential medium (MEM + GlutaMAX; Gibco, USA) containing 
increasing concentrations of DMSO (10%, 20%, 40% and 50%), 8% human platelet lysate (Macopharma, France) 
and 2 IU/ml heparin (LEO Pharma, Denmark). The vials were then placed on the cooling plate of the freezer 
Parameter Reference Results Our findings
Histological analysis
46 (human OT) 97% intact follicles
No intact follicles were found.
47 (human OT) 81% intact follicles
48 (human OT) 68% intact follicles
19 (human OT) 81% intact follicles
X-ray computed 
tomography
49 (human OT)
Frozen samples: OT could not be distinguished from 
the surrounding solution, although the presence of 
ice was less pronounced in the sample area. Average 
DMSO concentration: 11%
Thawed samples: effective removal of DMSO.
Frozen samples: no difference observed 
in attenuation between tissue and 
surrounding medium in two out of 
three samples, indicating that the system 
was well equilibrated. Average DMSO 
concentration: 38.1–45.2%.
Thawed samples: average DMSO 
concentration: −0.8% to 0.5%.
50 (bovine OT) Frozen samples: average DMSO concentration: 7.5%
51 (bovine OT)
Very small ice crystals observed at similar proportions 
throughout the whole vial, including the area where the 
tissue was located.
Freeze-substitution
52 (rabbit OT)
Frozen samples: densely packed and well delimited 
cellular material, but faster cooling rates caused more 
extensive disruption and shrinkage of tissue elements.
Vitrified samples: no ice formation.
No sign of ice crystal formation, 
confirmed by normal attachment 
between cells and no empty spaces in 
the tissue.
53 (sheep OT)
Frozen samples: widespread presence of large and small 
ice crystals throughout the extracellular matrix.
Vitrified samples: no sign of ice formation.
Transmission 
electron microscopy
54 (human OT)
Cytoplasmic vacuolization of GCs, oocyte, and 
fibroblasts. Microvilli between oocyte and GCs. Well 
preserved chromatin, basal membranes, gap junctions, 
and cell membranes. Normally organized collagen 
bundles.
Poorly preserved organelles: enlarged 
rough endoplasmic reticulum with 
detached and clustered ribosomes, 
mitochondrial degeneration, large 
vacuoles in the cytoplasm, detachment 
and disintegration of the lipid bilayer 
of cell membranes, disorganized 
chromatin, pyknosis.
55 (human OT) Intact follicles with no morphological deformation.
56 (human OT)
Oocytes with regularly shaped nuclei and finely 
dispersed chromatin. Mitochondria with moderately 
electron-dense matrices and curved cristae. Well 
preserved stromal cells.
18 (human OT)
Oocytes with prominent nucleoli, normally distributed 
euchromatin, and well preserved nuclear envelopes. 
Dense and well preserved mitochondrial matrices, well 
preserved GCs.
57 (human OT)
Healthy-looking follicles: large vesicular nuclei with 
dispersed chromatin, mitochondria with low-
density matrices and few peripheral cristae, close 
interdigitations between oocyte and GCs.
Table 2. Summary of the effect of conventional freezing on ovarian tissue compared to our findings after 
equilibrium vitrification. OT: ovarian tissue; GCs: granulosa cells.
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and remained open throughout the vitrification procedure, so tissue samples could move freely from one vial to 
another (Fig. 1). The entire procedure was performed inside a laminar flow hood under sterile conditions.
The samples were subjected to DMSO permeability in low temperatures, as demonstrated by the curve shown 
in Fig. 7. During each bath, ovarian tissue was kept submerged in medium for different periods of time, and 
moved in a constant up-down motion inside a small plastic basket in order to improve CPA perfusion, promoting 
faster equilibration of the tissue. In short, the ovarian cortical tissue was subjected to a 10% v/v DMSO bath at 
0 °C. The samples were then transferred to ever higher concentrations of DMSO concurrently with a temperature 
drop in the machine (20% DMSO at −4 °C, 40% DMSO at −8 °C, 50% DMSO at −25 °C). Finally, the tempera-
ture was reduced to −40 °C and the samples were placed in cryovials containing pre-cooled (−40 °C) 50% DMSO 
solution to proceed with vitrification. Temperature monitoring was carried out using a thermocouple data log-
ger deposited inside a side vial containing 50% DMSO solution. The vials were kept in liquid nitrogen vapors 
(approximately 2 cm above the liquid nitrogen surface) inside a cryotank for 5 minutes and vitrified to −150 °C. 
They were then submerged and stored in liquid nitrogen until warming.
Warming procedure. An adapted previously described slow-warming protocol13 was applied. Briefly, the 
cryovials were removed from the liquid nitrogen and placed in the pre-cooled programmable freezer (−40 °C) 
for 30 minutes. Thereafter, the solution was replaced in order to remove the CPA from the samples. Lower DMSO 
concentrations and higher temperatures were used, as shown in Fig. 7. The samples were kept in a 40% DMSO 
solution at −20 °C for 30 minutes, then in 30% DMSO for another 30 minutes. At 0 °C, 20% and 0% DMSO solu-
tions were utilized for 30 minutes each. Finally, three baths without DMSO lasting 5 minutes each were performed 
at room temperature (RT) (23 °C). The ovarian tissue fragments were then divided into 1 × 1 × 1 mm pieces that 
were either subjected to 24 hours of IVC, as described below, or fixed for TEM evaluation.
24 h in vitro culture. Fragments of fresh and warmed ovarian cortex were divided into 1 × 1 × 1 mm pieces 
and in vitro cultured in an attempt to restore the activity of follicles and other ovarian cells, and determine 
the impact of the cryopreservation procedure on their viability. The basic medium used was the same as that 
described for vitrification solution enriched with insulin, transferrin and selenium (ITS, Gibco, USA, 1%), pyru-
vic acid (2 mM), ascorbic acid (50 µg/ml) and antibiotics, namely amphotericin B, penicillin and streptomycin 
(Gibco, USA, 1%). The cortical pieces were kept inside a 5% carbon dioxide (CO2) incubator (Thermo Fischer 
Scientific, USA) at 37 °C. After 24 hours of culture, they were fixed in 4% paraformaldehyde and processed for 
histological analysis.
Histological analysis. After fixation in 4% paraformaldehyde, fresh and cultured samples underwent his-
tological processing (dehydration and clarification) before being embedded in paraffin. The blocks were then 
Figure 7. Equilibrium vitrification system. Cooling and warming curves achieved in the programmable freezer 
with the stepped vitrification device. DMSO: dimethyl sulfoxide; LN: liquid nitrogen.
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subjected to 5-µm-thick sectioning in a microtome and the slides were stained with hematoxylin and eosin for a 
general analysis of the tissue morphology and follicle counting.
Follicles were classified as morphologically normal when they had an intact spherical aspect, with uniform 
distribution of granulosa cells and a spherical oocyte showing no retractions or vacuoles attached to the sur-
rounding stroma. In the absence of these characteristics, follicles were considered to be degenerated. Only those 
exhibiting a visible oocyte nucleus were counted.
X-ray computed tomography. To determine CPA perfusion and removal efficiency, samples from three 
different patients were analyzed by computed tomography (CT) in order to ascertain DMSO concentrations in 
ovarian tissue after vitrification. A NanoCT scanner (Bioscan, USA; Mediso, Hungary) was used for this purpose, 
as previously reported15,43. The equipment was set up to maintain the samples at temperatures below −140 °C 
during vitrified tissue analysis. Once the temperature was reached, the samples were transferred from liquid 
nitrogen to the insulating container and CT image acquisition was performed. Specimens were then subjected to 
the warming protocol and NanoCT images were acquired at RT. This investigation was conducted to evaluate the 
washes for DMSO removal by searching for any remaining CPA.
Acquisition parameters included a 106 mA current for a voltage of 65 kV, exposure time per projection of 
500 ms, and 360 projections per rotation. Each image required 3 minutes for total acquisition and was recon-
structed to a spatial resolution of 0.2 mm. For imaging, three different software programs were used, namely 
Nucline software for acquisition (Mediso, Hungary), IVS image processing software for reconstruction (Invicro, 
USA), and PMOD 3.7 for analysis (PMOD Technologies LLC, Switzerland). For image visualization, a PMOD 
cold scale was applied, where the lowest attenuation is represented by a dark blue color and the highest attenua-
tion by intense red, passing through green, yellow and orange for intermediate attenuation values.
Freeze-substitution. The freeze-substitution technique enables visualization of possible ice formation in 
frozen or vitrified samples. Its main advantage is allowing preservation of tissue morphology as it is prior to 
warming, by fixing and processing fragments at low temperatures44. To this end, our samples were removed 
from the liquid nitrogen and transferred to a temperature of −80 °C. The medium was replaced with a solution 
containing 1% osmium tetroxide in methanol, which replaces water in tissues when changed over a series of 5 
days. The samples were kept at −20 °C for 24 hours, before being warmed to 4 °C and left for a further 2 hours. The 
ovarian fragments were then dehydrated in a propylene oxide solution and infiltrated with epoxy resin. Sections 
measuring 2.5 µm in thickness were obtained and stained with toluidine blue, before analysis by light microscopy.
Transmission electron microscopy. After fixation in Karnovsky’s solution, the samples were processed as 
previously described45. Ultrastructural organization was evaluated only in fresh controls and tissue obtained from 
3 patients soon after warming, which showed higher follicle density. Post-fixation was achieved with 1% osmium 
tetroxide and contrast was performed with 0.5% uranyl acetate. A solution of 0.1 M cacodylate buffer was used to 
wash the tissue between steps. Increasing concentrations of ethanol were utilized to dehydrate the tissue before its 
inclusion in epoxy resin (Agar Scientific, Essex, UK). The blocks were subjected to semi-thin sectioning (3 µm), 
stained with toluidine blue, and analyzed by light microscopy to localize follicles. Thereafter ultrathin sections 
(70–90 nm) were obtained and analyzed by TEM (Zeiss, Germany). For TEM evaluation, the morphological 
characteristics of the stroma, granulosa cells and oocytes, as well as their organelles, basal and plasmatic mem-
branes and nuclear envelope, were taken into account. Shape, morphology, distribution and the electron density 
of chromatin were also investigated.
Data availability
All data generated or analyzed during this study are included in this published article.
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